{"id":527067,"date":"2021-01-20T16:08:01","date_gmt":"2021-01-20T16:08:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=527067"},"modified":"2021-01-20T16:08:01","modified_gmt":"2021-01-20T16:08:01","slug":"obsessivecompulsive-disorder-market-analysis-leading-companies-emerging-drugs-and-epidemiology-forecast","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/obsessivecompulsive-disorder-market-analysis-leading-companies-emerging-drugs-and-epidemiology-forecast_527067.html","title":{"rendered":"Obsessive-Compulsive Disorder Market Analysis, Leading Companies, Emerging Drugs and Epidemiology Forecast"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1585677425.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Obsessive-Compulsive Disorder Market Analysis, Leading Companies, Emerging Drugs and Epidemiology Forecast\" src=\"https:\/\/www.abnewswire.com\/uploads\/1585677425.jpeg\" alt=\"Obsessive-Compulsive Disorder Market Analysis, Leading Companies, Emerging Drugs and Epidemiology Forecast\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Delveinsight Business Research LLP<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight&#8217;s &#8220;Obsessive-Compulsive Disorder Market Insights, Epidemiology, and Market Forecast 2030&#8221; report delivers an in-depth understanding of the Obsessive-Compulsive Disorder, historical and forecasted epidemiology as well as the Obsessive-Compulsive Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n<p style=\"text-align: justify;\"><strong>Obsessive-Compulsive Disorder (OCD)<\/strong> is an anxiety disorder in which people get recurring, unwanted thoughts, ideas, or sensations (obsessions) that make them feel driven to do something repetitively (compulsions). It is associated with a profoundly diminished quality of life, social isolation, and a substantial economic burden on society. The American Psychiatric Association (APA) states that females are affected at a slightly higher rate than men, and Obsessive-Compulsive Disorder affects people of all races and socio-economic backgrounds.<\/p>\n<p style=\"text-align: justify;\">In a new 2017 publication, the World Health Organization&rsquo;s &lsquo;Depression and other common mental disorders&rsquo; report, OCD was included in the &lsquo;anxiety disorders&rsquo; category. Obsessive-Compulsive Disorder ranks the tenth in the World Bank&rsquo;s and WHO&rsquo;s ten leading causes of disability and, in the case of women aged 15&ndash;44 years, Obsessive-Compulsive Disorder occupies the fifth position.<\/p>\n<p style=\"text-align: justify;\"><strong>Get FREE sample copy at:&nbsp;<\/strong><br \/><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/obsessive-compulsive-disorder-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\" target=\"_blank\">https:\/\/www.delveinsight.com\/sample-request\/obsessive-compulsive-disorder-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><span data-mce-mark=\"1\">The <strong>Obsessive-Compulsive Disorder market report<\/strong> also covers emerging drugs, current treatment practices, <\/span><span data-mce-mark=\"1\">Obsessive-Compulsive Disorder market share of the individual therapies, current and forecasted Obsessive-Compulsive Disorder Market Size<\/span><span data-mce-mark=\"1\"> from 2017 to 2030 segmented by seven major markets.&nbsp;<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">The report provides a detailed current <strong>Obsessive-Compulsive Disorder treatment practice\/algorithm<\/strong>, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.&nbsp;<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\"><img decoding=\"async\" style=\"display: block; margin-left: auto; margin-right: auto;\" title=\"Obsessive-Compulsive Disorder Market\" src=\"https:\/\/www.abnewswire.com\/uploads\/fb58252cd94247a139731e99fb594308.jpg\" alt=\"Obsessive-Compulsive Disorder Market\" \/><\/span><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Obsessive-Compulsive Disorder Market Key Facts<\/strong><\/p>\n<p style=\"text-align: justify;\">According to the NIMH, <strong>Obsessive-Compulsive Disorder<\/strong> currently affects approximately 1 in 40 adults and 1 in 100 children in the U.S.<\/p>\n<p style=\"text-align: justify;\">A study by Nakajima A. et al.,(2018), quoted that Obsessive-compulsive disorder (OCD) is a relatively common and frequently debilitating neuropsychiatric disorder that affects approximately 2% of the general population in Japan.<\/p>\n<p style=\"text-align: justify;\">According to a study titled &ldquo;<strong>Women Are at Greater Risk of Obsessive-Compulsive Disorder Than Men<\/strong>: A Meta-Analytic Review of Obsessive-Compulsive Disorder Prevalence Worldwide&#8221; conducted by Fawcettet E. J. al.,(2020), the overall aggregate current, period, and lifetime OCD prevalence estimates were 1.1%, 0.8%, and 1.3%, respectively.<\/p>\n<p style=\"text-align: justify;\"><strong>Key Benefits of Obsessive-Compulsive Disorder Market Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Obsessive-Compulsive Disorder market report<\/strong> provides an in-depth analysis of Obsessive-Compulsive Disorder Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span data-mce-mark=\"1\">The <strong>Obsessive-Compulsive Disorder market<\/strong> report will help in developing business strategies by understanding the <\/span><span data-mce-mark=\"1\">Obsessive-Compulsive Disorder Market trends &amp; developments<\/span><span data-mce-mark=\"1\">, key players and future market competition that will shape and drive the Obsessive-Compulsive Disorder market in the upcoming years.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span data-mce-mark=\"1\">The Obsessive-Compulsive Disorder market report covers <\/span><span data-mce-mark=\"1\"><strong>Obsessive-Compulsive Disorder current treatment practices<\/strong>, emerging drugs, market share<\/span><span data-mce-mark=\"1\"> of the individual therapies in 7 MM.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span data-mce-mark=\"1\">The report provides a detailed assessment of the <\/span><span data-mce-mark=\"1\">Obsessive-Compulsive Disorder market<\/span><span data-mce-mark=\"1\"> in terms of market drivers &amp; barriers, Unmet Needs, market opportunities, patient population,&nbsp; comparative analysis of pipeline products with detailed clinical profiles, and other factors.&nbsp;<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/obsessive-compulsive-disorder-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\" target=\"_blank\">Obsessive-Compulsive Disorder Market<br \/><\/a><\/strong><strong>The Obsessive-Compulsive Disorder market size is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, incremental healthcare spending across the world, and also expects the launch of some emerging therapies during the forecast period.<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;The <strong>Obsessive-Compulsive Disorder market outlook<\/strong> section of the report helps to build the detailed comprehension of the historic, current and forecasted Obsessive-Compulsive Disorder market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">The report gives a thorough detail of <\/span><strong>Obsessive-Compulsive Disorder market trend<\/strong><span data-mce-mark=\"1\"> of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.&nbsp;<\/span><\/p>\n<p style=\"text-align: justify;\"><strong>Obsessive-Compulsive Disorder Epidemiology<br \/><\/strong>The <strong>Obsessive-Compulsive Disorder epidemiology<\/strong> section covers insights about historical and current Obsessive-Compulsive Disorder patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.&nbsp;&nbsp;<\/span><\/p>\n<p style=\"text-align: justify;\"><strong>Obsessive-Compulsive Disorder Drugs Uptake and Key Market Players<\/strong><br \/><span data-mce-mark=\"1\">The <\/span><strong><span data-mce-mark=\"1\">Obsessive-Compulsive Disorder Drugs Uptake<\/span><\/strong><span data-mce-mark=\"1\"> section focuses on the rate of uptake of the potential drugs recently launched in the Obsessive-Compulsive Disorder market or expected to get launched in the market during the study period. The analysis covers <strong>Obsessive-Compulsive Disorder market<\/strong> uptake by drugs; patient uptake by therapies; and sales of each drug.&nbsp; &nbsp;&nbsp;<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">Report&rsquo;s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.<\/span><\/p>\n<p style=\"text-align: justify;\">The <strong>Obsessive-Compulsive Disorder market size<\/strong> is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, incremental healthcare spending across the world, and also expects the launch of some emerging therapies during the forecast period.<\/p>\n<p style=\"text-align: justify;\"><strong>Some of the key <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/obsessive-compulsive-disorder-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\" target=\"_blank\">companies in the Obsessive-Compulsive Disorder market<\/a> include:<\/strong><br \/><strong>Pfizer<\/strong><br \/><strong>GlaxoSmithKline<\/strong><br \/><strong>Eli Lilly and Company<\/strong><br \/><strong>Biohaven Pharmaceuticals<\/strong><br \/><strong>And others.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Obsessive-Compulsive Disorder Therapies Covered:<\/strong><br \/><strong>ZOLOFT<\/strong><br \/><strong>Paxil<\/strong><br \/><strong>PROZAC<\/strong><br \/><strong>Trigriluzole<\/strong><br \/><strong>And many others.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Table of Content<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">1. Key Insights<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">2. Executive Summary&nbsp;<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">3. Obsessive-Compulsive Disorder Competitive Intelligence Analysis<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">4. Obsessive-Compulsive Disorder Market Overview at a Glance<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">5. Obsessive-Compulsive Disorder Disease Background and Overview<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">6. Obsessive-Compulsive Disorder Patient Journey<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">7. Obsessive-Compulsive Disorder Epidemiology and Patient Population<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">8. Obsessive-Compulsive Disorder Treatment Algorithm, Current Treatment, and Medical Practices<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">9. Obsessive-Compulsive Disorder Unmet Needs<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">10. Key Endpoints of Obsessive-Compulsive Disorder Treatment<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">11. Obsessive-Compulsive Disorder Marketed Products<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">12. Obsessive-Compulsive Disorder Emerging Therapies<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">13. Obsessive-Compulsive Disorder Seven Major Market Analysis<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">14. Attribute Analysis<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">15. Obsessive-Compulsive Disorder Market Outlook (7 major markets)<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">16. Obsessive-Compulsive Disorder Access and Reimbursement Overview<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">17. KOL Views on the Obsessive-Compulsive Disorder Market.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">18. Obsessive-Compulsive Disorder Market Drivers<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">19. Obsessive-Compulsive Disorder Market Barriers<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">20. Appendix<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">21. DelveInsight Capabilities<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span data-mce-mark=\"1\">22. Disclaimer<\/span><\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports<\/strong><br \/><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/obsessive-compulsive-disorder-epidemiology-forecast\">Obsessive-Compulsive Disorder Epidemiology Forecast<br \/><\/a><\/strong>DelveInsight&#8217;s Obsessive-Compulsive Disorder &#8211; Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Obsessive-Compulsive Disorder in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong><span data-mce-mark=\"1\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/obsessive-compulsive-disorder-pipeline-insight\">Obsessive-Compulsive Disorder Pipeline Insights<br \/><\/a><\/span><\/strong>Obsessive-Compulsive Disorder Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Obsessive-Compulsive Disorder market.<\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;About DelveInsight<\/strong><br \/><strong>DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.<\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56421.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Shruti Thakur<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=obsessivecompulsive-disorder-market-analysis-leading-companies-emerging-drugs-and-epidemiology-forecast\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +919650213330<br \/><strong>Address:<\/strong>304 S. Jones Blvd. 2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=obsessivecompulsive-disorder-market-analysis-leading-companies-emerging-drugs-and-epidemiology-forecast\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Delveinsight Business Research LLP DelveInsight&#8217;s &#8220;Obsessive-Compulsive Disorder Market Insights, Epidemiology, and Market Forecast 2030&#8221; report delivers an in-depth understanding of the Obsessive-Compulsive Disorder, historical and forecasted epidemiology as well as the Obsessive-Compulsive Disorder market trends in the United States, EU5 &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/obsessivecompulsive-disorder-market-analysis-leading-companies-emerging-drugs-and-epidemiology-forecast_527067.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[435,405,417,406,404],"tags":[],"class_list":["post-527067","post","type-post","status-publish","format-standard","hentry","category-Europe","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/527067","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=527067"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/527067\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=527067"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=527067"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=527067"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}